ABILITY BIOLOGICS
Dead / Abandoned — Abandoned — failure to respond (as of 10 Jul 2025)
What this means for you
This application is over — abandoned 27 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98657872
- Mark type
- Stylized text
- Filed
- 19 Jul 2024
- Abandoned
- 27 Jun 2025
- Attorney of record
- Max Vern
Goods and services
- Class 001 — Chemicals: antibody products and molecules for scientific and medical purposes;
- Class 005 — Pharmaceuticals: antibody products and molecules acting as immune modulators for scientific and medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories;
- Class 042 — Scientific and technological services: antibody profiling for scientific research purposes, for discovery and development of new biotherapeutics; operation of scientific database and website regarding research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development; clinical trials; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service [PaaS] for analyzing molecular and clinical data to develop antibodies against immune targets; analysis in the field of molecular biology; molecular analysis and product optimization for the purpose of pharmaceutical development;
Owner
- ABILITY BIOLOGICS INC, Montreal, Quebec, CA
Prosecution history
- 10 Jul 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 10 Jul 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 26 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Mar 2025 — NON-FINAL ACTION E-MAILED
- 26 Mar 2025 — NON-FINAL ACTION WRITTEN
- 05 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Feb 2025 — NON-FINAL ACTION E-MAILED
- 05 Feb 2025 — NON-FINAL ACTION WRITTEN
- 29 Jan 2025 — ASSIGNED TO EXAMINER
- 15 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Jul 2024 — NEW APPLICATION ENTERED